Clinical Development Director

November 29, 2018

Matthew Womack

Bailey Fisher Executive Search is pleased to have assisted Endomag with the search for a Clinical Development Director, a new position created to lead the company’s clinical activities during a period of rapid growth.

Endomag is a venture backed medical devices business, providing a better standard of cancer care for patients around the globe.  The incidence of cancer is growing, and with it the demand for better, faster and less expensive solutions for diagnosis and treatment. With the aim of bringing cancer care to everyone, everywhere, Endomag is developing a clinical platform that uses safe magnetic fields to power diagnostic and therapeutic devices, avoiding the safety, workflow and availability concerns of ionizing radiation. Endomag was founded in 2007 as a spin-out from University College London and the University of Houston, and is backed by investors including Draper Esprit. The company has won a number of awards including an Innovate UK SME Innovation Award, was a finalist for the prestigious MacRobert Award from the Royal Academy of Engineering (2015), and more recently was awarded a Queen’s Award for Enterprise Innovation.

The Clinical Development Director search was managed by Iain Hopper, Director of Health Technology & Life Sciences at Bailey Fisher.  The search resulted in the appointment of Matthew Womack, who brings extensive experience within both early stage growth business and big pharma.

More insight